Apimeds’ Subsidiary MindWave Signs 12-Month Software Development And Technology Services Agreement With Flash Sports & Media To Build And Operate FlashChain
MindWave Innovations Inc. ("MindWave"), a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE:APUS), has signed a 12-month software development and technology services agreement with New York-based
Apimeds' software company MindWave signed a deal to build technology for a sports company. When a company gets new customer contracts, it shows people want what they make.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.